Dr. Chris Rider
Chris joined the lab in January 2015 after completing a PhD at the University of Calgary supervised by Drs. Robert Newton and Mark Giembycz. His PhD work focused on glucocorticoid resistance and how this could be combated with long acting beta2-adrenoceptor agonists, in the context of asthma and COPD. Chris is applying his expertise with in vitro epithelial cell models to examine how air pollution alters immune responses in COPD and asthma, examining effects on DNA methylation, miRNA and gene expression.
Through collaborations with researchers in the Tebbutt, Sin and Kobor labs at UBC, he is leveraging his bioinformatics skills to analyse data collected from current and earlier clinical trials. When not in the lab or at a computer, Chris enjoys running, sailing, kayaking, camping and snowboarding.